The World Health Organization (WHO) and World Bank Group today launched a new mechanism to strengthen global health security through stringent independent monitoring and regular reporting of preparedness to tackle outbreaks, pandemics, an
The government of the Democratic Republic of Congo, with the support of the World Health Organization (WHO) and partners, is preparing to vaccinate high-risk populations against Ebola virus disease (EVD) in affected health zones.
The World Health Organization (WHO) published the recommendations of the Strategic Advisory Group of Experts on Immunization (SAGE) on the use of Dengvaxia® on May 27, 2016, and subsequently a WHO position paper on dengue vaccine on July
Immunization saves millions of lives and is widely recognized as one of the world’s most successful and cost-effective health interventions.
Nearly 1 billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from WHO, Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners.
Each year countries around the globe commemorates World TB Day on March 24 to raise public awareness about the devastating health, social and economic consequences of tuberculosis (TB) and to step up efforts to end the global TB epidemic.
A new report published today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicates that the number of new tuberculosis (TB) patients has been decreasing at an average rate of 4.3
Surgical site infections (SSI) are the most frequent type of infection acquired during healthcare delivery in developing countries. Infections are also the most frequent complication following surgery to occur across Africa.
The periodic replacement of viruses contained in influenza vaccines is necessary in order for the vaccines to be effective due to the constant evolving nature of influenza viruses, including those circulating and infecting humans.
For the purposes of the R&D Blueprint, the World Health Organization (WHO) has developed a special tool for determining which diseases and pathogens to prioritize for research and development in public health emergency contexts.